Moreover, some clinically approved anticancer drugs, such as VCP inhibitors [9], DNA-PK inhibitors [10], Smac mimetics [9], and BCL-XL inhibitors [11], can potentiate the oncolytic effect of M1 virus in various types of cancers. This evidence concerns the gene BCL2L1 and cancer.